Patent Assignment
Reel/Frame 056659/0705
Assignment of Assignor's Interest
Recorded: 2021-06-24
Pages: 8
Assignors
SUGITA, SUNAO
Executed: 2021-05-26
MANDAI, MICHIKO
Executed: 2021-05-27
TAKAHASHI, MASAYO
Executed: 2021-05-31
YAMASAKI, SUGURU
Executed: 2021-05-31
Assignees
RIKEN
2-1, HIROSAWA, WAKO-SHI, SAITAMA, 351-0198, JAPAN
SUMITOMO DAINIPPON PHARMA CO., LTD.
6-8, DOSHO-MACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-8524, JAPAN
SUMITOMO CHEMICAL COMPANY, LIMITED
27-1, SHINKAWA 2-CHOME, CHUO-KU, TOKYO, 104-8260, JAPAN
Covered Property
(1)
Therapeutic Drug for Disease Accompanied by Disorders in Retinal Cells or Retinal Tissue
Application:
17/418,003 →
Publication:
US 2024/0207483
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Jul 14, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD
Reel/Frame 060507/0750 →
Assignment of Assignor's Interest
Jan 23, 2024
From: SUMITOMO CHEMICAL COMPANY, LIMITED
To: SUMITOMO PHARMA CO., LTD
Reel/Frame 066212/0380 →
Corrective Assignment to Correct the the Assignee Name Previously Recorded at Reel: 062212 Frame: 0380. Assignor(S) Hereby Confirms the Assignment.
Jan 25, 2024
From: SUMITOMO CHEMICAL COMPANY, LIMITED
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 066371/0033 →
Assignment of Assignor's Interest
Sep 29, 2025
From: SUMITOMO PHARMA CO., LTD.
To: RACTHERA CO., LTD.
Reel/Frame 072399/0820 →